BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33108450)

  • 1. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
    Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
    Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.
    Stolyarov Y; Mirocha J; Mamelak AN; Ben-Shlomo A
    Pituitary; 2018 Feb; 21(1):41-49. PubMed ID: 29143885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
    McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
    World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease.
    Ironside N; Chatain G; Asuzu D; Benzo S; Lodish M; Sharma S; Nieman L; Stratakis CA; Lonser RR; Chittiboina P
    Eur J Endocrinol; 2018 Mar; 178(3):255-263. PubMed ID: 29330227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.
    Asuzu D; Chatain GP; Hayes C; Benzo S; McGlotten R; Keil M; Beri A; Sharma ST; Nieman L; Lodish M; Stratakis C; Lonser RR; Oldfield EH; Chittiboina P
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2179-2187. PubMed ID: 28323961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.
    Lindsay JR; Oldfield EH; Stratakis CA; Nieman LK
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2057-64. PubMed ID: 21508126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.
    Guaraldi F; Zoli M; Asioli S; Corona G; Gori D; Friso F; Pasquini E; Bacci A; Sforza A; Mazzatenta D
    J Endocrinol Invest; 2020 Oct; 43(10):1463-1471. PubMed ID: 32215861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Serum Cortisol and Cushing Disease Recurrence in Patients With Corticotroph Adenomas.
    Catalino MP; Moore DT; Ironside N; Munoz AR; Coley J; Jonas R; Kearns K; Min L; Vance ML; Jane JA; Laws ER
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3287-3294. PubMed ID: 37290036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.
    Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Cushing's Disease: Changing Trend from Microscopic to Endoscopic Surgery.
    Bora SK; Suri A; Khadgawat R; Tandon N; Suri V; Chand Sharma M; Satyarthee G; Singh M; Tandon V; Agarwal D; Kumar R; Chandra PS; Gurjar HK; Borkar S; Gupta DK; Singh PK; Kale SS
    World Neurosurg; 2020 Feb; 134():e46-e54. PubMed ID: 31491582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy.
    Nadezhdina EY; Rebrova OY; Grigoriev AY; Ivaschenko OV; Azizyan VN; Melnichenko GA; Dedov II
    Pituitary; 2019 Dec; 22(6):574-580. PubMed ID: 31506907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
    Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
    J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing's Disease.
    Vassiliadi DA; Balomenaki M; Asimakopoulou A; Botoula E; Tzanela M; Tsagarakis S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4878-4885. PubMed ID: 27662440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.